血液生化指标与糖尿病合并高血压患者肾损伤的相关性分析

doi:10.3969/j.issn.1671-7171.2025.04.031

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1158 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the correlation between blood biochemical indicators and kidney injury in patients with diabetes combined with hypertension.【Methods】 A total of 320 patients with diabetes combined with hypertension were divided into a non-injury group (152 cases) and a kidney injury group (168 cases) based on the presence or absence of kidney injury. All patients underwent relevant blood biochemical tests, and the correlation between various indicators and the occurrence of kidney injury was analyzed. Multi-factor logistic regression was used to identify the influencing factors.【Results】 There was no significant difference in fasting blood glucose (FBG), 2-hour postprandial blood glucose (2hPG), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) between the two groups (P>0.05). The levels of glycated hemoglobin (HbA1c), cystatin C (cys C), serum creatinine (Scr), and serum β₂-microglobulin (β₂-MG) in the kidney injury group were higher than those in the non-injury group (P<0.05). Serum HbA1c, cys C, Scr, and β₂-MG levels were positively correlated with the occurrence of kidney injury in patients with diabetes combined with hypertension (P<0.05). Logistic regression analysis showed that HbA1c, cys C, Scr, and β₂-MG levels were important influencing factors for the occurrence of kidney injury (OR>1, P<0.05).【Conclusion】 Serum levels of HbA1c, cys C, Scr, and β₂-MG are significantly positively correlated with the occurrence of kidney injury in patients with diabetes combined with hypertension, and these indicators are important influencing factors for occurrence of kidney injury, which can provide reference for clinical practice.

Key words： Diabetes Mellitus Hypertension Kidney Injury Correlation of Data

Received: 23 October 2024

PACS:

R587.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHAO Liqin
	CHEN Fangfang

Cite this article:

ZHAO Liqin,CHEN Fangfang. Correlation Analysis of Blood Biochemical Indicators and Kidney Injury in Patients with Diabetes and Hypertension[J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(4): 670-672.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.04.031 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I4/670

[1] 张云琪,许宵钰,马郭薇,等.糖尿病并发症发病机制及治疗药物研究进展[J].中国药理学通报,2024,40(10):1808-1813.
[2] 张琳,谢荣荣,杨芳远,等.肾小管及肾小球标志物在2型糖尿病患者不同肾损伤阶段诊断价值的研究[J].首都医科大学学报,2024,45(3):429-437.
[3] 刘丽丽.利格列汀联合达格列净治疗2型糖尿病并高血压的效果观察[J].实用中西医结合临床,2024,24(8):52-54.
[4] 林妹妹.血常规、尿常规与炎性标志物联合检测诊断糖尿病患者早期肾损伤的价值[J].黑龙江医药,2024,37(4):935-938.
[5] 孟洁,张丽媛.空腹血糖和血脂指标联合检测在糖尿病患者生化检验中的应用[J].实用检验医师杂志,2024,16(1):28-31.
[6] 赵欣,王博超,甘营奇.黄葵胶囊联合达格列净对老年糖尿病肾病患者肾功能及内分泌激素水平的影响[J].中国老年学杂志,2024,44(1):69-71.
[7] 檀淼,孔怡然,陈素枝,等.加味升降散对早期糖尿病肾病患者肾小管功能的影响[J].世界中医药,2024,19(14):2160-2165.
[8] 陈占科,陈凯丽,应春苗,等.糖尿病肾脏疾病预后影响因素的COX比例风险回归模型分析[J].中华中医药学刊,2024,42(2):28-33.
[9] 江从斌,王丽芳,姜阳萍.糖尿病肾病患者早期诊断中mAlb、HbA1c、cys C检测对早期肾损伤的评估研究[J].黑龙江医药,2024,37(1):38-41.
[10] 焦艳红.原发性高血压肾损伤患者血清cys C、Hcy水平的变化及临床意义研究[J].现代诊断与治疗,2024,35(10):1518-1520.
[11] 刘风.脓毒症合并急性肾损伤患者血清cys C、CRP、PCT水平变化及其与肾功能转归的关系研究[J].江西医药,2024,59(8):758-761.
[12] 周萍,夏卫珍,汪小芳.血清β₂-微球蛋白、Scr、BUN在糖尿病早期肾损伤评估中的应用[J].中国血液流变学杂志,2023,33(2):273-276.
[13] 邱爽,孔卓,王芳.Cys C、C1q、β₂-MG、Urea、UA检测对初诊多发性骨髓瘤患者合并肾损伤的诊断价值[J].医学研究杂志,2024,53(4):138-142.